Glaxo Sues Hospira Over Quality of Flu Vaccine Supply

GlaxoSmithKline Plc sued Hospira Inc. seeking more than $25 million in damages over the quality of influenza vaccine supplies.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.